Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Paul Durrington

Showing results (31-40 of 43) with videos related to

Pageof 5
Sort By:
Journal of Occupational and Environmental Medicine|July 12, 2003
Paraoxonase in Persian Gulf War veteransMatthew Hotopf, Michael Ian Mackness, Vasilis Nikolaou, et al.
Diabetes|July 21, 2011
Total soluble and endogenous secretory receptor for advanced glycation end products as predictive biomarkers of coronary heart disease risk in patients with type 2 diabetes: an analysis from the CARDS trialHelen M Colhoun, D John Betteridge, Paul Durrington, et al.
The Journal of Clinical Endocrinology and Metabolism|May 15, 2014
Impairment of high-density lipoprotein resistance to lipid peroxidation and adipose tissue inflammation in obesity complicated by obstructive sleep apneaRahul Yadav, Michael France, Reza Aghamohammadzadeh, et al.
Journal of the American Heart Association|September 17, 2015
Effect of Extended-Release Niacin on High-Density Lipoprotein (HDL) Functionality, Lipoprotein Metabolism, and Mediators of Vascular Inflammation in Statin-Treated PatientsRahul Yadav, Yifen Liu, See Kwok, et al.
Atherosclerosis|July 5, 2011
ESC/EAS Guidelines for the management of dyslipidaemias: the Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS), Alberico L Catapano, Zeljko Reiner, et al.
European Heart Journal|June 30, 2011
ESC/EAS Guidelines for the management of dyslipidaemias: the Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS), Zeljko Reiner, Alberico L Catapano, et al.
The Journal of Clinical Investigation|January 24, 2009
Postreceptor insulin resistance contributes to human dyslipidemia and hepatic steatosisRobert K Semple, Alison Sleigh, Peter R Murgatroyd, et al.
Frontiers in Immunology|December 1, 2017
Effect of Roux-en-Y Bariatric Surgery on Lipoproteins, Insulin Resistance, and Systemic and Vascular Inflammation in Obesity and DiabetesRahul Yadav, Salam Hama, Yifen Liu, et al.
Atherosclerosis|September 2, 2011
ESC/EAS Guidelines for the management of dyslipidaemias The Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS)Alberico L Catapano, Zeljko Reiner, Guy De Backer, et al.
Diabetologia|October 6, 2018
Serum kidney injury molecule 1 and β<sub>2</sub>-microglobulin perform as well as larger biomarker panels for prediction of rapid decline in renal function in type 2 diabetesMarco Colombo, Helen C Looker, Bassam Farran, et al.
Pageof 5

Showing results (31-40 of 43) with videos related to

Sort By:
Pageof 5
Journal of Occupational and Environmental Medicine|July 12, 2003
Paraoxonase in Persian Gulf War veteransMatthew Hotopf, Michael Ian Mackness, Vasilis Nikolaou, et al.
Diabetes|July 21, 2011
Total soluble and endogenous secretory receptor for advanced glycation end products as predictive biomarkers of coronary heart disease risk in patients with type 2 diabetes: an analysis from the CARDS trialHelen M Colhoun, D John Betteridge, Paul Durrington, et al.
The Journal of Clinical Endocrinology and Metabolism|May 15, 2014
Impairment of high-density lipoprotein resistance to lipid peroxidation and adipose tissue inflammation in obesity complicated by obstructive sleep apneaRahul Yadav, Michael France, Reza Aghamohammadzadeh, et al.
Journal of the American Heart Association|September 17, 2015
Effect of Extended-Release Niacin on High-Density Lipoprotein (HDL) Functionality, Lipoprotein Metabolism, and Mediators of Vascular Inflammation in Statin-Treated PatientsRahul Yadav, Yifen Liu, See Kwok, et al.
Atherosclerosis|July 5, 2011
ESC/EAS Guidelines for the management of dyslipidaemias: the Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS), Alberico L Catapano, Zeljko Reiner, et al.
European Heart Journal|June 30, 2011
ESC/EAS Guidelines for the management of dyslipidaemias: the Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS), Zeljko Reiner, Alberico L Catapano, et al.
The Journal of Clinical Investigation|January 24, 2009
Postreceptor insulin resistance contributes to human dyslipidemia and hepatic steatosisRobert K Semple, Alison Sleigh, Peter R Murgatroyd, et al.
Frontiers in Immunology|December 1, 2017
Effect of Roux-en-Y Bariatric Surgery on Lipoproteins, Insulin Resistance, and Systemic and Vascular Inflammation in Obesity and DiabetesRahul Yadav, Salam Hama, Yifen Liu, et al.
Atherosclerosis|September 2, 2011
ESC/EAS Guidelines for the management of dyslipidaemias The Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS)Alberico L Catapano, Zeljko Reiner, Guy De Backer, et al.
Diabetologia|October 6, 2018
Serum kidney injury molecule 1 and β<sub>2</sub>-microglobulin perform as well as larger biomarker panels for prediction of rapid decline in renal function in type 2 diabetesMarco Colombo, Helen C Looker, Bassam Farran, et al.
Pageof 5